Comparison between antigenemia and a quantitative-competitive polymerase chain reaction for the diagnosis of cytomegalovirus infection after heart transplantation

Transplantation

Volumn 71, Issue 3, 2001, Pages 412-417

  Camargo, Luis Fernando A ^a,c   Uip, David E ^a   Simpson, Andrew A G ^b   Caballero, Otávia ^b   Stolf, Noedir A G ^a   Vilas Boas, Lucy S ^a   Pannuti, Cláudio S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CYTOMEGALIC INCLUSION BODY DISEASE; HEART TRANSPLANTATION; HUMAN; INTERMETHOD COMPARISON; NEUTROPHIL; POLYMERASE CHAIN REACTION; PREDICTION AND FORECASTING; PRIORITY JOURNAL; REFERENCE VALUE;

EID: 0035865243     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200102150-00013     Document Type: Article

References (38)

1. The transplanted kidney as a source of cytomegalovirus infection
2. Clinical manifestations of renal allograft derived primary cytomegalovirus infection
3. Cytomegalovirus infection: A quantitative prospective study of three hundred twenty consecutive renal transplants
4. Infecção pelo citomegalovirus em pacientes submetidos a transplante renal: Estudo de 20 casos
5. The correlation between symptomatic CMV infection and CMV antigenemia in heart allograft recipients
6. Association of quantitative cytomegalovirus antigenemia with symptomatic infection in solid organ transplant patients
7. A longitudinal prospective study of cytomegalovirus pp 65 antigenemia in renal transplant recipients
8. The role of PCR in the diagnosis and management of CMV in solid organ recipients: What is the predictive value for the development of disease and should PCR be used to guide antiviral therapy
9. Detection of human cytomegalovirus in renal transplantation: Comparison of four diagnostic methods: DNA in sera by polymerase chain reaction (PCR), DNA in leukocyte by PCR, pp65 leukocytic antigenemia and viremia
10. Predictive value of cytomegalovirus DNA detection by polymerase chain reaction in blood and bronchoalveolar lavage in lung transplant patients
11. Preemptive therapy in immunocompromised hosts
12. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus disease in cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant patients: A randomized controlled trial
13. High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial
14. pp65 antigenemia as a marker of future CMV disease and mortality in HIV-infected patients
15. Preemptive treatment for the prevention of cytomegalovirus disease in lung and heart transplant recipients
16. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: A comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay
17. Immunocytochemical assay for cytomegalovirus detection in peripheral blood for renal transplant patients in clinical practice
18. Quantitation of human cytomegalovirus DNA in bone marrow transplant recipients
19. Quantitation of cytomegalovirus (CMV) DNA in leukocytes of human immunodeficiency virus-infected subjects with and without CMV disease by using PCR and the SHARP signal detection system
20. Cytomegalovirus antigenemia in acquired immunodeficiency syndrome patients with untreated cytomegalovirus retinitis
21. A novel, internally competitive polymerase chain reaction for quantification of human cytomegalovirus DNA in human leukocytes
22. Cytomegalovirus disease is associated with increased cost and hospital length of stay among orthotopic liver transplant recipients
23. Infecçòes causadas por vírus em 100 pacientes submetidos a transplante cardíaco
24. Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology and the shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation
25. Detection of IgM antibodies against cytomegalovirus: Comparison of two radioimmunoassays, enzyme-linked immunoabsorbent assay ans immunofluorescent antibody test
26. Correlation of cytomegalovirns DNA levels with response to antiviral therapy in cardiac and renal allograft recipients
27. Comparative evaluation of the cytomegalovirus DNA load in polymorphonuclear leukocytes plasma of human immunodeficiency virus-infected subjects
28. Human cytomegalovirus (CMV) DNA in plasma reflects quantity of CMV DNA present in leukocytes
29. Quantitative detection of human cytomegalovirus DNA in lung transplant recipients
30. Quantification of human cytomegalovirus DNA using the polymerase chain reaction
31. Low-stringency-PCR (LSPCR) allows entirely internally standardized DNA quantitation
32. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion
33. The treatment of chronic viral hepatitis
34. Highly sensitive single-step PCR protocol for diagnosis and monitoring of human cytomegalovirns infection in renal transplant recipients
35. Late cytomegalovirus disease in marrow transplantation is predicted by virus load in plasma
36. Immunocytochemical assay for cytomegalovirus detection in peripheral blood for renal transplant patients in clinical practice
37. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: A randomized double-blind study